Chemocentryx (CCXI) Holder Fosun International LTD Has Decreased Its Position by $580,740; Channing Capital Management Has Lowered Its H.B. Fuller Co. (FUL) Position by $18.86 Million as Market Value Rose

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Channing Capital Management Llc decreased its stake in H.B. Fuller Co. (FUL) by 39.24% based on its latest 2018Q4 regulatory filing with the SEC. Channing Capital Management Llc sold 449,104 shares as the company’s stock rose 9.09% with the market. The institutional investor held 695,475 shares of the home furnishings company at the end of 2018Q4, valued at $29.68M, down from 1.14 million at the end of the previous reported quarter. Channing Capital Management Llc who had been investing in H.B. Fuller Co. for a number of months, seems to be less bullish one the $2.58B market cap company. The stock increased 0.42% or $0.21 during the last trading session, reaching $50.64. About 58,543 shares traded. H.B. Fuller Company (NYSE:FUL) has risen 3.56% since April 18, 2018 and is uptrending. It has underperformed by 0.81% the S&P500. Some Historical FUL News: 28/03/2018 – HB FULLER CO FUL.N SEES FY 2018 ADJUSTED SHR $3.10 TO $3.40; 12/04/2018 – H.B. Fuller Increases Quarterly Dividend; 28/03/2018 – H.B. FULLER REAFFIRMS YR FORECAST; 28/03/2018 – HB FULLER CO – CONFIRM FISCAL YEAR 2018 ADJUSTED DILUTED EPS GUIDANCE $3.10 TO $3.40; 12/04/2018 – HB Fuller Raises Dividend to 15.5c Vs. 15c; 28/03/2018 – HB FULLER CO – STILL EXPECT TO INVEST APPROXIMATELY $90 MLN IN CAPITAL ITEMS IN 2018; 09/04/2018 – LAUNCH: HB Fuller $2.139b TLB for Repricing; Call April 10; 28/03/2018 – HB FULLER CO – PLANS TO DELIVER $465 MLN IN EBITDA THIS YEAR AND $600 MLN IN EBITDA BY 2020 REMAIN ON TRACK; 04/05/2018 – Victory Capital Management Inc. Exits Position in HB Fuller; 28/03/2018 – HB FULLER 1Q NET REV. $713.1M, EST. $664.5M

Fosun International Ltd decreased its stake in Chemocentryx Inc (CCXI) by 36.51% based on its latest 2018Q4 regulatory filing with the SEC. Fosun International Ltd sold 58,074 shares as the company’s stock rose 6.99% with the market. The institutional investor held 100,976 shares of the health care company at the end of 2018Q4, valued at $1.06M, down from 159,050 at the end of the previous reported quarter. Fosun International Ltd who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $696.46 million market cap company. The stock decreased 1.83% or $0.23 during the last trading session, reaching $12.06. About 91,012 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 18, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It dived, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Charles Schwab Inv Mgmt invested in 0% or 49,177 shares. Trexquant Limited Partnership owns 33,717 shares for 0.02% of their portfolio. D E Shaw & Incorporated reported 214,899 shares stake. Qs Limited Liability Company reported 643 shares. Tower Capital Limited (Trc) reported 257 shares. Wasatch Advisors stated it has 2.32M shares or 0.34% of all its holdings. Paw Capital holds 0.68% or 50,000 shares. 19,032 were reported by Los Angeles Management And Equity Inc. Ny State Common Retirement Fund owns 25,400 shares. Moreover, Ameritas Prtn Incorporated has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 2,120 shares. Pnc Financial has invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Bb&T Secs Ltd Liability owns 114,827 shares. Vanguard Incorporated owns 1.36M shares for 0% of their portfolio. Sei Invests reported 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Sio Cap Limited Com invested in 169,257 shares or 0.67% of the stock.

Fosun International Ltd, which manages about $1.67 billion US Long portfolio, upped its stake in Biomarin Pharmaceutical Inc (NASDAQ:BMRN) by 9,000 shares to 89,950 shares, valued at $7.56 million in 2018Q4, according to the filing. It also increased its holding in Merck & Co Inc (NYSE:MRK) by 7,780 shares in the quarter, for a total of 87,880 shares, and has risen its stake in Jpmorgan Chase & Co (NYSE:JPM).

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Benzinga.com which released: “Cancer Biology Clinical Research Seeking Answers at Cellular Level – Benzinga” on March 26, 2019, also Benzinga.com with their article: “Benzinga’s Top Upgrades, Downgrades For March 27, 2019 – Benzinga” published on March 27, 2019, Globenewswire.com published: “Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” on April 16, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Benzinga.com and their article: “60 Stocks Moving In Wednesday’s Mid-Day Session – Benzinga” published on March 27, 2019 as well as Benzinga.com‘s news article titled: “71 Biggest Movers From Yesterday – Benzinga” with publication date: March 28, 2019.

Since October 26, 2018, it had 0 insider purchases, and 7 selling transactions for $1.80 million activity. 7,211 shares were sold by Schall Thomas J., worth $86,554 on Wednesday, November 7. KANAYA SUSAN M also sold $457,747 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) on Tuesday, January 22.

Investors sentiment increased to 1.26 in 2018 Q4. Its up 0.45, from 0.81 in 2018Q3. It is positive, as 19 investors sold FUL shares while 55 reduced holdings. 33 funds opened positions while 60 raised stakes. 50.56 million shares or 2.28% more from 49.44 million shares in 2018Q3 were reported. Athena Cap Advisors Ltd Com invested in 10 shares or 0% of the stock. Kwmg Limited Liability Co holds 0% or 8 shares. State Of Tennessee Treasury Department holds 0.01% or 22,733 shares in its portfolio. Employees Retirement Association Of Colorado reported 229,931 shares. Mutual Of America Cap Management Ltd Company has invested 0% in H.B. Fuller Company (NYSE:FUL). Glenmede Co Na invested in 0% or 195 shares. Credit Suisse Ag holds 51,581 shares. Teachers Retirement Systems Of The State Of Kentucky owns 15,403 shares or 0.01% of their US portfolio. 695,475 are owned by Channing Capital Management Ltd Company. 364,291 are held by Invesco Limited. Arizona State Retirement Sys holds 0.01% of its portfolio in H.B. Fuller Company (NYSE:FUL) for 42,229 shares. 7,730 were reported by Amalgamated Financial Bank. Cooke And Bieler Ltd Partnership reported 488,490 shares or 0.42% of all its holdings. Janney Montgomery Scott Limited Liability Corp has 0.01% invested in H.B. Fuller Company (NYSE:FUL) for 18,500 shares. Moody Bankshares Tru Division invested in 128 shares or 0% of the stock.

More notable recent H.B. Fuller Company (NYSE:FUL) news were published by: Seekingalpha.com which released: “H.B. Fuller declares $0.16 dividend – Seeking Alpha” on April 04, 2019, also Prnewswire.com with their article: “HB Fuller Unveils the Next Generation of Adhesive Solutions for Woodworking at Ligna 2019 – PRNewswire” published on April 10, 2019, Globenewswire.com published: “Research Report Identifies CASI Pharmaceuticals, WestRock, HB Fuller, Osisko Gold Royalties, Kopin, and Redfin with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement – GlobeNewswire” on April 10, 2019. More interesting news about H.B. Fuller Company (NYSE:FUL) were released by: Seekingalpha.com and their article: “Stocks To Watch: Apple Makes Its Video-Streaming Move – Seeking Alpha” published on March 23, 2019 as well as Benzinga.com‘s news article titled: “6 Stocks Moving In Wednesday’s After-Hours Session – Benzinga” with publication date: March 27, 2019.

H.B. Fuller Company (NYSE:FUL) Institutional Positions Chart


Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *